Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Seattle-Denver Center of Innovation (COIN)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

COIN Investigators & Staff

COIN Investigators

 

Margaret A. Fitzpatrick, MD, MS
Title: Infectious Diseases Physician
Associate Professor of Medicine, Division of Infectious Diseases, University of Colorado
Contact: margaret.fitzpatrick@va.gov
Location: Denver
University of Colorado webpage
See Dr. Fitzpatrick's Dimensions profile that includes: publications, grants, datasets, patents and clinical trials
My research interests include multi-drug resistant and healthcare-associated infections and antimicrobial stewardship in high-risk special patient populations, particularly those with chronic neurologic injury. My research interests also encompass patient-reported outcomes related to infectious diseases and antimicrobial use.
Morbidity and mortality related to multi-drug resistant and healthcare-associated infections remains high, and has increased during the COVID-19 pandemic. Veterans with chronic neurologic injuries and other rehabilitation needs are high risk for these infections. Effective prevention of such infections through judicious use of antibiotics and other strategies is critical.
My current work focuses on improving management of urinary tract infections (UTIs) in patients with bladder dysfunction due to chronic neurologic diseases. We hope to design and intervention to optimize UTI management via improved patient-provider communication and patient recognition and understanding of UTI signs and symptoms. Improved UTI management leads to more appropriate diagnosis and antibiotic use which, in turn, improves rehabilitative health, reduces illness and disability from infections and antibiotic side effects, and optimizes quality of life for high priority Veteran populations.

The following images visualize Dr. Fitzpatrick's work. The word cloud is drawn from publication titles. The research collaboration map shows research relationships (click the image to enlarge):

Dr. Fitzpatrick's publication titles indicate primary work is multi-drug resistant and healthcare-associated infections and antimicrobial stewardship
Word cloud from pub titles
Dr. Fitzpatrick's collaborations are primarily from the University of Colorado
Research collaboration map
The following research fields have been used to summarize Dr. Fitzpatrick's publications and grants. The categories are based on 67 publications and 1 grants.
Publications Grants
Infectious Diseases Aging
Prevention Injury (total) Accidents/Adverse Effects
Clinical Research Neurosciences
Emerging Infectious Diseases Clinical Research
Antimicrobial Resistance Rehabilitation
Vaccine Related Infectious Diseases
Biodefense Neurodegenerative
Dental/Oral and Craniofacial Disease Urologic Diseases
Neurodegenerative  
Injury (total) Accidents/Adverse Effects  

Return to Top

Recent Publications

 

2022

 

Evans CT, Fitzpatrick MA, Poggensee L, Gonzalez B, Gibson G, Jurasic MM, Echevarria K, McGregor JC, Gellad WF, Suda KJ. High Prescribing of Antibiotics is Associated with High Prescribing of Opioids in Medical and Dental Providers. Pharmacotherapy. 2022 Jul 22. doi: 10.1002/phar.2720. Epub ahead of print. PMID: 35869691
Learn more about this publication on Dimensions

Vivo A, Fitzpatrick MA, Suda KJ, Jones MM, Perencevich EN, Rubin MA, Ramanathan S, Wilson GM, Evans ME, Evans CT. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study. BMC Infect Dis. 2022 May 24;22(1):491. doi: 10.1186/s12879-022-07436-w. PMCID: PMC9128216. PMID: 35610601
Learn more about this publication on Dimensions

Suda KJ, Fitzpatrick MA, Gibson G, Jurasic MM, Poggensee L, Echevarria K, Hubbard CC, McGregor JC, Evans CT. Antibiotic prophylaxis prescriptions prior to dental visits in the Veterans' Health Administration (VHA), 2015-2019. Infect Control Hosp Epidemiol. 2022 Feb 22:1-10. doi: 10.1017/ice.2021.521. Epub ahead of print. PMID: 35189986
Learn more about this publication on Dimensions

Wilson GM, Evans CT, Fitzpatrick MA, Poggensee L, Gibson G, Jurasic MM, Echevarria K, Suda KJ. Clostridioides difficile infection following dental antibiotic prescriptions in a cohort of US veterans. Infect Control Hosp Epidemiol. 2022 Feb 21:1-3. doi: 10.1017/ice.2021.516. Epub ahead of print. PMID: 35188097
Learn more about this publication on Dimensions

Fitzpatrick MA, Suda KJ, Poggensee L, Vivo A, Wilson G, Jones MM, Evans M, Safdar N, Evans CT. Treatment of extensively-drug resistant (XDR) Acinetobacter and impact on clinical outcomes in U.S. veterans affairs (VA) medical centers. Am J Infect Control. 2022 Jan 30:S0196-6553(22)00052-9. doi: 10.1016/j.ajic.2022.01.011. Epub ahead of print. PMID: 35108579
Learn more about this publication on Dimensions

Return to Top

Grants & Funding

 

Optimizing Management of Urinary Tract Infections in Patients with Neurogenic Bladder through Improved Knowledge of Provider Practice and Patient-reported Outcomes

NIH website: https://reporter.nih.gov/project-details/10507754